Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Gene Therapy

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 27
At a glance
Powered by AI
The key takeaways are that genes encode proteins, mutations can cause genetic disorders, and gene therapy aims to introduce normal genes to treat genetic disorders.

Genes are segments of DNA located on chromosomes that encode proteins. Proteins carry out most cellular functions, and mutations in genes can alter protein function and cause genetic disorders.

Gene therapy aims to introduce normal genes into cells containing defective genes in order to produce sufficient amounts of a normal gene product and correct genetic disorders. Its goals are to compensate for nonfunctional genes, replace abnormal genes, repair abnormal genes, or change gene regulation.

Gene Therapy

Presented by Mankaran Singh, Dinesh Kumar, Deepak Sharma, Gurmeet Singh M.Pharmacy PHARMACEUTICS CT Institute of Pharmaceutical sciences Jalandhar, INDIA AICTE , PCI approved

Genes
Are carried on a chromosome

The basic unit of heredity


Encode how to make a protein DNARNA proteins

Proteins carry out most of lifes function.


When altered causes dysfunction of a protein When there is a mutation in the gene, then it will change the codon, which will change which amino acid is called for which will change the conformation of the protein which will change the function of the protein. Genetic disorders result from mutations in the genome.

Picture of a Chromosome

What is Gene Therapy


Introduction of normal genes into cells that contain defective genes to reconstitute a missing protein product GT is used to correct a deficient phenotype so that sufficient amounts of a normal gene product are synthesized to improve a genetic disorder

There are four approaches:


1. 2. 3. 4. A normal gene inserted to compensate for a nonfunctional gene. An abnormal gene traded for a normal gene An abnormal gene repaired through selective reverse mutation Change the regulation of gene pairs

Types of gene therapy


1. Germ line therapy: In the case of germ line gene therapy, germ cells, i.e., sperm or eggs, are modified by the introduction of functional genes, which are integrated into their genomes. Therefore, the change due to therapy would be heritable and would be passed on to later generations. 2. Somatic gene therapy: In the case of somatic gene therapy, the therapeutic genes are transferred into the somatic cells of a patient. Any modifications and effects will be restricted to the individual patient only, and will not be inherited by the patient's offspring or later generations. 3. Enhancement genetic engineering: This type of gene transfer is done to alter a specific traits in animals Eg : introduction of growth hormone to increase height. 4. Eugenic genetic engineering: Novel genes transferred to improve complex traits such as intelligence and personality but this type of therapy is not done on humans because its too complicated and beyond our capabilities.

The First Case


The first gene therapy was performed on September 14th, 1990 Ashanti DeSilva was treated for SCID (Severe combined immunodeficiency) By W. French Anderson and Michael Blaese. Doctors removed her white blood cells, inserted the missing gene into the WBC, and then put them back into her blood stream. This strengthened her immune system Only worked for a few months

How It Works
A vector delivers the therapeutic gene into a patients target cell The target cells become infected with the viral vector The vectors genetic material is inserted into the target cell Functional proteins are created from the therapeutic gene causing the cell to return to a normal state

Different Delivery Systems are Available


In vivo versus ex vivo In vivo = Delivery of genes takes place in the body In vivo techniques usually utilize viral vectors Ex vivo = Delivery takes place out of the body, and then cells are placed back into the body Eg: Electroporation, Liposome, Gold bullets (fired within helium pressurized gun, Retrotransposons (jumping genes early days) Human artificial chromosomes Retrotransposons (also called transposons via RNA intermediates) are genetic elements that can amplify themselves in a genome and are ubiquitous components of the DNA of many eukaryotic organisms)

VIRAL VECTORS
1. Adenoviral vectors:
Double-stranded DNA viruses, usually cause benign respiratory disease; serotypes 2 and 5 are used as vectors. Can infect dividing and non-dividing cells, can be produced at high titers. Replication-deficient adenovirus vectors can be generated by replacing the E1 or E3 gene, which is essential for replication.

The recombinant vectors are then replicated in cells that express the products of the E1 or E3 gene and can be generated in very high concentrations.
Cells infected with recombinant adenovirus can express the therapeutic gene, but because essential genes for replication are deleted, the vector cant replicate.

Adenoviral vectors- Limitations


Adenoviral vectors can infect cells in vivo, causing them to express high levels of the transgene. However, expression lasts for only a short time (510 days post-infection). Immune response is the reason behind the short-term expression. Immune reaction is potent, eliciting both the cell-killing cellular response and the antibody producing humoral as response. Humoral response results in generation of antibodies to adenoviral proteins and prevents any subsequent infection if a second injection of the recombinant adenovirus is given.

2.Adeno-associated viral vectors:


AAV is a simple, non-pathogenic, single stranded DNA virus dependent on the helper virus (usually adenovirus) to replicate. It has two genes (cap and rep), sandwiched between inverted terminal repeats that define the beginning and the end of the virus and contain the packaging sequence. The cap gene encodes viral capsid proteins and the rep gene product is involved in viral replication and integration. It can infect a variety of cell types and in the presence of the rep gene product, the viral DNA can integrate preferentially into human chromosome 19.

AAV vectors:

To produce an AAV vector, the rep and cap genes are replaced with a transgene. The total length of the insert cannot exceed 4.7 kb, the length of the wild type genome.

Production of the recombinant vector requires that rep and cap are provided in trans along with the helper virus gene products.
The current method is to cotransfect two plasmids, one for the vector and another for rep and cap into cells infected with adenovirus. This method is cumbersome, low yielding and prone to contamination with adenovirus and wild type AAV. Interest in AAV vectors is due to their integration into the host genome allowing prolonged gene expression.

Adeno-associated virus vectors:


Advantages: All viral genes removed Safe Transduction of nondividing cells Stable expression Disadvantages: Small genome limits size of foreign DNA Labor intensive production Status of genome not fully elucidated.

3.Retroviral vectors:
Retroviral vectors are based on Moloney murine leukemia virus (Mo-MLV) which is capable of infecting both mouse and human cells. The viral genes, gag, pol and env, are replaced with the transgene of interest and expressed on plasmids in the packaging cell line. Because the non-essential genes lack the packaging sequence, they are not included in the virion particle. To prevent recombination resulting in replication competent retroviruses, all regions of homology with the vector backbone is removed.

Retroviral vectors- Limitations


A critical limitation of retroviral vectors is their inability to infect nondividing cells, such as those that make up muscle, brain, lung and liver tissue. The cells from the target tissue are removed, grown in vitro and infected with the recombinant vector, the target cells are producing the foreign protein are then transplanted back into the animal (ex vivo gene therapy).

Problems with expression being shut off, prolonged expression is difficult to attain.
Expression is reduced by inflammatory interferons acting on viral LTRs, as the retroviral DNA integrates, viral LTR promoters are inactivated.

Possibility of random integration of vector DNA into the host chromosome.

4. Lentiviral Vectors
Belong to the retrovirus family but can infect both dividing and nondividing cells. They are more complicated than retroviruses, containing an additional six proteins, tat, rev, vpr, vpu, nef and vif. Human immunodeficiency virus (HIV) has been disabled and developed as a vector for in vivo gene delivery. Low cellular immune response, thus good possibility for in vivo gene delivery with sustained expression over six months.

No potent antibody response.

5.Herpes Simplex Viruses


Double stranded DNA viruses that infect neurons Ex. Herpes simplex virus type 1

Genetic Defects that are Candidates for Gene Therapy

NON_ VIRAL METHODS


PHYSICAL METHODS Microinjection Direct DNA ligation Gene gun Magic bullets CHEMICAL METHODS Using detergent mixtures Receptor mediated gene delivery

THANK YOU

You might also like